SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-14-043516
Filing Date
2014-02-10
Accepted
2014-02-10 17:29:11
Documents
1
Group Members
BAY CITY CAPITAL FUND V CO-INVESTMENT FUND, L.P.BAY CITY CAPITAL FUND V, L.P.BAY CITY CAPITAL MANAGEMENT V LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d673546dsc13da.htm SC 13D/A 81763
  Complete submission text file 0001193125-14-043516.txt   83515
Mailing Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111 415.676.3830
BAY CITY CAPITAL LLC (Filed by) CIK: 0001288452 (see all company filings)

IRS No.: 943272448 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87481 | Film No.: 14590390
SIC: 2834 Pharmaceutical Preparations